Mycoplasma: tiny wall‑less bacteria and their medical significance

Key characteristics

• Cell structure: a flexible plasma cell membrane contains the cytoplasm. Sterol incorporation, such as cholesterol, stabilizes the membrane in many species.
• Gram reaction: typically described as gram‑negative in staining behavior, though the absence of a true wall makes Gram classification of limited value.
• Size and form: among the smallest free‑living cells; they can pass through filters that retain most bacteria and exhibit variable, often filamentous or coccoid, shapes.
• Metabolism: many are fastidious, requiring host‑derived nutrients and often unable to synthesise essential factors de novo.

History and taxonomy

Mycoplasmas were first recognized in the early 20th century as “pleuropneumonia‑like organisms” (PPLO) because of their association with animal respiratory disease and their unusual growth requirements. Over time, improved microscopy, culture techniques and molecular methods clarified their classification within the class Mollicutes and separated them from other bacteria with cell walls. Modern taxonomy relies on genetic data to define species and relationships.

Ecology, pathogenicity and examples

Many mycoplasmas are parasitic on plants, animals and humans; others are saprophytic and live on decaying organic matter. They can survive with limited or without atmospheric oxygen, depending on the species. Some are important human pathogens: M. genitalium has been linked to non‑gonococcal urethritis and reproductive tract infections, while M. pneumoniae is a recognized cause of atypical pneumonia. Because many species are pathogenic, they are medically significant in both community and hospital settings.

Diagnosis, treatment and laboratory impact

Detection of mycoplasmas uses specialized culture media, serology and increasingly molecular tests (PCR). Standard culture can be slow and technically demanding. Treatments favor agents that inhibit protein synthesis or DNA replication; common classes used include macrolides, tetracyclines and fluoroquinolones rather than beta‑lactams. Many typical antibiotics that target cell walls—such as penicillin—are ineffective. In addition to causing disease, mycoplasmas are notorious contaminants of cell cultures, where unnoticed infection can alter experimental results.

Distinguishing features and significance

1. Absence of cell wall confers intrinsic resistance to cell wall–targeting drugs and produces variable staining results.
2. Small genome and minimal biosynthetic capacity make many species dependent on host factors for growth.
3. Their ability to adhere tightly to host cells contributes to persistence and immune evasion, complicating eradication.

Because of their unusual biology and clinical relevance, mycoplasmas occupy an important niche in microbiology. They are studied both as minimal models of cellular life and as pathogens requiring targeted diagnostic and therapeutic approaches. For further reading see general references and laboratory guidelines on identification and management (Mycoplasma overview, bacterial resources, structural notes, membrane biology, staining caveats, sterol requirements, antibiotic considerations, penicillin limits, pathogenic species, ecology, oxygen tolerance, M. genitalium, clinical syndromes, M. pneumoniae).